Ondine Biomedical Inc (OBI) - Total Liabilities

Latest as of December 2025: GBX10.91 Million GBX ≈ $1.33K USD

Based on the latest financial reports, Ondine Biomedical Inc (OBI) has total liabilities worth GBX10.91 Million GBX (≈ $1.33K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Ondine Biomedical Inc equity growth rate to track the company's year-over-year net asset growth rate.

Ondine Biomedical Inc - Total Liabilities Trend (2001–2025)

This chart illustrates how Ondine Biomedical Inc's total liabilities have evolved over time, based on quarterly financial data. See OBI cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Ondine Biomedical Inc Competitors by Total Liabilities

The table below lists competitors of Ondine Biomedical Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Eurasia Mining LSE:EUA	UK	GBX1.88 Million
FINEQIA INTERN. INC. O.N. F:FNQA	Germany	€55.02 Million
Portofino Resources Inc V:POR	Canada	CA$1.50 Million
Network Media Group Inc V:NTE	Canada	CA$9.01 Million
Yolo SA WAR:YOL	Poland	zł27.26 Million
LABOCANNA S.A. ZY-10 F:9Y2	Germany	€7.71 Million
Eco Animal Health Group Plc LSE:EAH	UK	GBX21.57 Million
PDG Realty S.A. Empreendimentos e Participações SA:PDGR3	Brazil	R$3.98 Billion

Liability Composition Analysis (2001–2025)

This chart breaks down Ondine Biomedical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see OBI market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.23	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.13	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.76	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ondine Biomedical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ondine Biomedical Inc (2001–2025)

The table below shows the annual total liabilities of Ondine Biomedical Inc from 2001 to 2025.

Year	Total Liabilities	Change
2025-12-31	GBX10.91 Million ≈ $1.33K	+83.50%
2024-12-31	GBX5.95 Million ≈ $723.33	+62.92%
2023-12-31	GBX3.65 Million ≈ $443.98	-25.91%
2022-12-31	GBX4.92 Million ≈ $599.23	+9.86%
2021-12-31	GBX4.48 Million ≈ $545.45	-87.71%
2020-12-31	GBX36.46 Million ≈ $4.44K	+25.80%
2019-12-31	GBX28.99 Million ≈ $3.53K	+29.42%
2018-12-31	GBX22.40 Million ≈ $2.72K	+84.24%
2017-12-31	GBX12.16 Million ≈ $1.48K	+439.10%
2010-12-31	GBX2.25 Million ≈ $274.35	+68.11%
2009-12-31	GBX1.34 Million ≈ $163.19	-16.65%
2008-12-31	GBX1.61 Million ≈ $195.79	-25.50%
2007-12-31	GBX2.16 Million ≈ $262.81	+15.34%
2006-12-31	GBX1.87 Million ≈ $227.85	+151.16%
2005-12-31	GBX745.61K ≈ $90.72	+218.65%
2003-08-31	GBX233.99K ≈ $28.47	+62.35%
2002-08-31	GBX144.13K ≈ $17.54	+148.43%
2001-08-31	GBX58.02K ≈ $7.06	--

About Ondine Biomedical Inc

LSE:OBI UK Biotechnology

Market Cap

$821.79K

GBX6.75 Billion GBX

Market Cap Rank

#30675 Global

#841 in UK

Share Price

GBX13.00

Change (1 day)

+0.00%

52-Week Range

GBX8.00 - GBX18.00

All Time High

GBX58.50